|
Sep 13, 2021
|
Dynavax Provides Update on its COVID-19 Collaboration with Valneva
|
|
|
Sep 09, 2021
|
Dynavax to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
|
|
|
Sep 02, 2021
|
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
|
Aug 23, 2021
|
Medigen Vaccine Biologics Announces Launch of Its COVID-19 Vaccine MVC-COV1901 Adjuvanted with Dynavax's CpG 1018 Adjuvant
|
|
|
Aug 04, 2021
|
Dynavax Announces Second Quarter 2021 Financial Results
|
|
|
Aug 03, 2021
|
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
|
Jul 21, 2021
|
Dynavax to Report Second Quarter 2021 Financial Results and Host Conference Call on August 4, 2021
|
|
|
Jul 06, 2021
|
Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate
|
|
|
Jul 02, 2021
|
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
|
Jun 30, 2021
|
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate
|
|
